Tirzepatide Improves 24-Hour BP in Obesity-Related Hypertension

Medically reviewed by Carmen Pope, BPharm. Last updated on Feb 7, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Feb. 7, 2024 -- For patients with obesity and hypertension, tirzepatide improves 24-hour blood pressure (BP), according to a research letter published online Feb. 5 in Hypertension.

James A. de Lemos, M.D., from the University of Texas Southwestern Medical Center in Dallas, and colleagues examined the effect of tirzepatide on 24-hour BP, measured by ambulatory BP monitoring (ABPM) in patients with obesity but without type 2 diabetes. Data were included for 600 participants in a substudy of the randomized SURMOUNT-1 trial that examined the effects of once-weekly tirzepatide (5, 10, and 15 mg) in individuals with a body mass index ≥27 kg/m2, who underwent 24-hour ABPM at baseline and week 36; 494 participants had valid data at both baseline and week 36.

The researchers found that compared with placebo, treatment with each tirzepatide dose reduced 24-hour systolic BP at 36 weeks. The placebo-adjusted systolic BP change from baseline was −7.4, −10.6, and −8.0 mm Hg for 5, 10, and 15 mg tirzepatide, respectively. For both day and nighttime BP, the results were consistent, with significant reductions seen for each tirzepatide dose versus placebo. Change in 24-hour systolic BP correlated with change in body weight in pooled tirzepatide analyses. In mediation analyses, changes in ambulatory systolic BP were partially mediated by changes in weight.

"These data provide further evidence for the potential benefits of tirzepatide on cardiometabolic health and cardiovascular outcomes," the authors write.

Several authors disclosed ties to pharmaceutical companies, including Eli Lilly, which manufactures tirzepatide and funded the study.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords